MetLife Investment Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $62.5K | Buy |
|
|||||
|
2023
Q3 | $39.4K | Buy |
|
|||||
|
2023
Q2 | $32.6K | Sell |
|
|||||
|
2023
Q1 | $34.4K | Buy |
|
|||||
|
2022
Q4 | $41.8K | Buy |
|
|||||
|
2022
Q3 | $61.8K | Sell |
|
|||||
|
2022
Q2 | $60.8K | Sell |
|
|||||
|
2022
Q1 | $197K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2.73M | Sell |
|
|||||
|
2020
Q4 | $3.74M | Buy |
|
|||||
|
2020
Q3 | $2.6M | Sell |
|
|||||
|
2020
Q2 | $1.85M | Buy |
|
|||||
|
2020
Q1 | $973K | Buy |
|
|||||
|
2019
Q4 | $1.55M | Hold |
|
|||||
|
2019
Q3 | $934K | Buy |
|
|||||
|
2019
Q2 | $1.16M | Buy |
|
|||||
|
2019
Q1 | $702K | Buy |
|
|||||
|
2018
Q4 | $365K | Hold |
|
|||||
|
2018
Q3 | $405K | Hold |
|
|||||
|
2018
Q2 | $424K | Buy |
|